FindTrial
Sign In

The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease

The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease - The examination of the clinical response of celecoxib in Darier's disease and Hailey-Hailey disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010191
Enrollment
10
Registered
2013-04-01
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drier&#39

Interventions

celecoxib

Sponsors

Juntendo university gradurate school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A person of Darier disease and Hailey-Hailey disease which was already diagnosed in Juntendo University.

Exclusion criteria

Exclusion criteria: 1 The patients who have an allergy to celecoxib 2 The patients with the aspirin asthma and gastrointestinal ulceration 3 The patients with serious hepatopathy and nephropathy 4 The patients with the heart disease 5 The patients during the pregnancy or breast-feeding

Design outcomes

Primary

MeasureTime frame
We evaluate it with clinical symptom degree of improvement 1 erythema area 2 erosion area 3 egree of improvement of a pain and itch using a VAS scale—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026